Status and phase
Conditions
Treatments
About
The main objective of this study is to determine the maximum tolerated dose (MTD) of Oratecan in combination with capecitabine
Full description
Besides the main objective, there are 4 other objectives as follows:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
21 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal